Back to 
MAVERICK CAPITAL LTD
MAVERICK CAPITAL LTD
LGND
Showing 0 of 2 quarters
Position history for MAVERICK CAPITAL LTD's holdings in LIGAND PHARMACEUTICALS INC
No. Maverick Capital exited its LGND (Ligand Pharmaceuticals) position in Q1 2020. Its Q4 2019 13F listed 16,489 shares worth $1.7M. Maverick Capital first reported LGND in Q4 2019 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.